Trial Profile
An Open-label, Single-dose, Randomized, Crossover Study to Determine the Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsule in Solid Tumor Cancer Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jul 2012
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 01 Jun 2011 Status changed from active, no longer recruiting to completed.
- 17 May 2011 Results will be presented at ASCO-2011, according to a Genta media release.